Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v10-EN Version v9-FR
Language English French
Date Updated 2020-04-07 2020-04-06
Drug Identification Number 02469456 02469456
Brand name ETHACRYNATE SODIUM FOR INJECTION USP ETHACRYNATE SODIUM FOR INJECTION USP
Common or Proper name ETHACRYNATE SODIUM FOR INJECTION USP ETHACRYNATE SODIUM FOR INJECTION USP
Company Name STERIMAX INC STERIMAX INC
Ingredients ETHACRYNIC ACID ETHACRYNIC ACID
Strength(s) 50MG 50MG
Dosage form(s) POWDER FOR SOLUTION POWDER FOR SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 1 VIAL 1 VIAL
ATC code C03CC C03CC
ATC description HIGH-CEILING DIURETICS HIGH-CEILING DIURETICS
Reason for shortage Delay in shipping of the drug. Delay in shipping of the drug.
Anticipated start date 2019-10-15 2019-10-15
Actual start date
Estimated end date 2020-04-06 2020-04-06
Actual end date 2020-04-06 2020-04-06
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments
Health Canada comments